MedPath

TRANXENE CAP 7.5MG

TRANXENE CAP 7.5MG

Discontinued
DIN Number

00264946

Drug Class

Human

Market Date

Dec 31, 1976

Company
HC

ABBOTT LABORATORIES, LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00264946
AIG Number0108895002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA05 CLORAZEPATE POTASSIUM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CLORAZEPATE DIPOTASSIUMActive
Strength: 7.5 MG / CAP
Monograph: CLORAZEPATE DIPOTASSIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.